Dr. Johan Luthman appointed EVP and Head of Research & Development in Lundbeck
Valby, Denmark, 22 January 2019 - H. Lundbeck A/S (Lundbeck) today announced that Dr. Johan Luthman has been appointed Executive Vice President and Head of Research & Development in Lundbeck. Johan will assume his new role and join the Executive Management on 1 March 2019 and brings approximately 28 years of experience in pharmaceutical R&D. Johan has been exposed to R&D management from companies such as Eisai, Merck & Co and AstraZeneca and has taken through development of small molecules and biopharmaceuticals (mAb and protein therapeutics) programs in neuroscience (neurology,